HHealthcare Read More Johnson & Johnson, U.S. agree on drug discounts, new plantsJanuary 9, 2026 Key Terms tariffs regulatory Tariffs are taxes imposed by a government on goods…
HHealthcare Read More Johnson & Johnson MedTech submits Ottava surgical robot to FDAJanuary 8, 2026 Johnson & Johnson MedTech (NYSE: JNJ) + announced today that it submitted its Ottava surgical robotic system to…
HHealthcare Read More The Zacks Analyst Blog Eli Lilly, Medtronic, Intuitive Surgical, Regeneron Pharmaceuticals and Johnson & JohnsonJanuary 7, 2026 Chicago, IL – January 6, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog.…
HHealthcare Read More Got $500? 3 Dividend-Paying Healthcare Stocks to Buy and Hold ForeverDecember 31, 2025 Bristol Myers Squibb is a pharmaceutical giant with a solid dividend history. Medtronic is a high-yield medical device…
HHealthcare Read More Johnson & Johnson halts mid-stage trial of experimental eczema drugDecember 26, 2025 Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg |…
HHealthcare Read More Here’s Why Johnson & Johnson (JNJ) Surged in Q3December 25, 2025 Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” third-quarter 2025 investor letter. A copy of…
PPersonal finance Read More 5 Dividends That Beat Social Security’s Unpredictable COLA AdjustmentsDecember 18, 2025 24/7/ Wall St. Social Security COLA dropped from 8.7% in 2023 to 2.5% in 2025. Realty Income pays…
EEconomy Read More Stock market today: Live updatesDecember 17, 2025 Traders work on the floor of the New York Stock Exchange (NYSE) at the opening bell in New…
PPersonal finance Read More 5 Dividend Powerhouses That Belong in Every Retirement Portfolio Right NowDecember 11, 2025 24/7 Wall St Verizon offers the highest yield at 6.59% with a 0.32 beta and 19 consecutive years…
HHealthcare Read More Johnson & Johnson (JNJ) Announces Updated Results From the Phase 3 CARTITUDE-4 StudyDecember 10, 2025 Johnson & Johnson (NYSE:JNJ) is one of the best pharma stocks to invest in. Johnson & Johnson (NYSE:JNJ) announced…
HHealthcare Read More 1 Major Factor Behind the Healthcare Sector’s Recent SurgeDecember 10, 2025 Eli Lilly’s GLP-1 drug became the world’s best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other…
HHealthcare Read More Johnson & Johnson Buys Prostate Cancer Treatment-Maker Halda for $3.1 BillionNovember 24, 2025 Johnson & Johnson has had the year 2025 circled, highlighted, bolded and underlined on its calendar for a…